Protein Description

Gene Symbol DPYD
Entrez ID 1806
Uniprot ID Q12882
Description dihydropyrimidine dehydrogenase
Chromosomal Location chr1: 97,077,743-97,921,049
Ontology GO ID GO Term Definition Evidence

BP

GO:0006145

purine nucleobase catabolic process

The chemical reactions and pathways resulting in the breakdown of purine nucleobases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, which include adenine and guanine.

IMP

BP

GO:0006208

pyrimidine nucleobase catabolic process

The chemical reactions and pathways resulting in the breakdown of pyrimidine nucleobases, 1,3-diazine, organic nitrogenous bases.

IMP|ISS

BP

GO:0006210

thymine catabolic process

The chemical reactions and pathways resulting in the breakdown of thymine, 5-methyluracil, one of the two major pyrimidine bases present (as thymidine) in DNA but not found in RNA other than (as ribothymidine) in transfer RNA, where it is a minor base.

IDA

BP

GO:0006212

uracil catabolic process

The chemical reactions and pathways resulting in the breakdown of uracil, 2,4-dioxopyrimidine, one of the pyrimidine bases occurring in RNA, but not in DNA.

IDA

BP

GO:0006214

thymidine catabolic process

The chemical reactions and pathways resulting in the breakdown of thymidine, deoxyribosylthymine thymine 2-deoxyriboside, a deoxynucleoside very widely distributed but occurring almost entirely as phosphoric esters in deoxynucleotides and deoxyribonucleic acid, DNA.

IDA

BP

GO:0019483

beta-alanine biosynthetic process

The chemical reactions and pathways resulting in the formation of beta-alanine (3-aminopropanoic acid), an achiral amino acid and an isomer of alanine. It occurs free (e.g. in brain) and in combination (e.g. in pantothenate) but it is not a constituent of proteins.

IEA

BP

GO:0046135

pyrimidine nucleoside catabolic process

The chemical reactions and pathways resulting in the breakdown of one of a family of organic molecules consisting of a pyrimidine base covalently bonded to a sugar ribose (a ribonucleoside) or deoxyribose (a deoxyribonucleoside).

TAS

BP

GO:0055114

oxidation-reduction process

A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.

IEA

CC

GO:0005737

cytoplasm

All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

IDA

CC

GO:0005829

cytosol

The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.

IDA|TAS

MF

GO:0017113

dihydropyrimidine dehydrogenase (NADP+) activity

Catalysis of the reaction: 5,6-dihydrouracil + NADP+ = uracil + NADPH + H+.

IDA|IMP|ISS|TAS

MF

GO:0042803

protein homodimerization activity

Interacting selectively and non-covalently with an identical protein to form a homodimer.

IDA|ISS

MF

GO:0046872

metal ion binding

Interacting selectively and non-covalently with any metal ion.

IEA

MF

GO:0050660

flavin adenine dinucleotide binding

Interacting selectively and non-covalently with FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2.

ISS

MF

GO:0050661

NADP binding

Interacting selectively and non-covalently with nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NADP+, or the reduced form, NADPH.

ISS

MF

GO:0051539

4 iron, 4 sulfur cluster binding

Interacting selectively and non-covalently with a 4 iron, 4 sulfur (4Fe-4S) cluster; this cluster consists of four iron atoms, with the inorganic sulfur atoms found between the irons and acting as bridging ligands.

IEA

Domain ID Description

IPR005720

Dihydroorotate dehydrogenase domain

IPR009051

Alpha-helical ferredoxin

IPR013785

Aldolase-type TIM barrel

IPR017896

4Fe-4S ferredoxin-type, iron-sulphur binding domain

IPR017900

4Fe-4S ferredoxin, iron-sulphur binding, conserved site

IPR023753

FAD/NAD(P)-binding domain

IPR028261

Dihydroprymidine dehydrogenase domain II

Pathway ID Pathway Term Pathway Source

hsa00240

Pyrimidine metabolism

KEGG

hsa00410

beta-Alanine metabolism

KEGG

hsa00770

Pantothenate and CoA biosynthesis

KEGG

hsa00983

Drug metabolism - other enzymes

KEGG

hsa01100

Metabolic pathways

KEGG

WP3945

TYROBP Causal Network

WikiPathways

WP1601

Fluoropyrimidine Activity

WikiPathways

UMLS CUI UMLS Term

C0004352

Autistic Disorder

C0008074

Child Development Disorders, Pervasive

C0009375

Colonic Neoplasms

C0009404

Colorectal Neoplasms

C0018671

Head And Neck Neoplasms

C0023014

Language Development Disorders

C0024121

Lung Neoplasms

C0027627

Neoplasm Metastasis

C0027765

Nervous System Disorder

C0027947

Neutropenia

C0028754

Obesity

C0030297

Pancreatic Neoplasm

C0031117

Peripheral Neuropathy

C0034139

Purine-Pyrimidine Metabolism, Inborn Errors

C0036341

Schizophrenia

C0038356

Stomach Neoplasms

C0270612

Leukoencephalopathies

C1458155

Mammary Neoplasms

C1959620

Dihydropyrimidine Dehydrogenase Deficiency

C2239176

Liver Carcinoma

No tissues found.

No databases found.

Pubmed ID Author Year Title

22617121

Ouandaogo et al.

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation

22951915

Haozi et al.

2012

Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome

Gene Symbol Entrez ID Uniprot ID Score

RPE

6120

Q96AT9

0.49

LXN

56925

Q9BS40

0.63

GOPC

57120

Q9HD26

0.73

GAPDH

2597

P04406

0.49

TRNT1

51095

Q96Q11

0.49

C9orf64

84267

Q5T6V5

0.49

NAXE

128240

Q8NCW5

0.49

CHAC2

494143

Q8WUX2

0.49

CLK1

1195

P49759

0.52

TSHZ1

10194

Q6ZSZ6

0.63